Alberto Ovejero-Llorente
Leioa, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Cannabinoid agonist WIN55,212-2 prevents scopolamine-induced impairment of spatial memory in rats.
Journal: European journal of pharmacology
Published: March 24, 2025
Sphingosine 1-phosphate receptor subtype 1 (S1P1) activity in the course of Alzheimer's disease.
Journal: Neurobiology of disease
Published: July 15, 2024
Cognitive improvement via cortical cannabinoid receptors and choline-containing lipids.
Journal: British journal of pharmacology
Published: March 07, 2024
Cannabinoid Receptors and Glial Response Following a Basal Forebrain Cholinergic Lesion.
Journal: ACS pharmacology & translational science
Published: April 11, 2022
Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: October 21, 2021
Handling and novel object recognition modulate fear response and endocannabinoid signaling in nucleus basalis magnocellularis.
Journal: The European journal of neuroscience
Published: July 01, 2021
Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease.
Journal: ACS chemical neuroscience
Published: May 26, 2021
Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: June 06, 2018
Lipid mapping of the rat brain for models of disease.
Journal: Biochimica et biophysica acta. Biomembranes
Published: December 19, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026